Madhalaysnimo
Madhalaysnimo micnaheedu waa inaadan uur qaadi karin (uur yeelan).
Waxaa jira 2 nooc oo madhalays ah:
- Madhalaysnimo aasaasi ah waxaa loola jeedaa lammaanaha aan uur yeelan ka dib ugu yaraan 1 sano oo galmo ah iyada oo aan la isticmaalin hababka ka hortagga uurka.
- Madhalaysnimo labaad ayaa loola jeedaa lamaanayaasha awooday inay uur qaadaan ugu yaraan hal mar, laakiin hadda aan awoodin.
Waxyaabo badan oo jireed iyo shucuur ah ayaa sababi kara madhalaysnimo. Waxaa laga yaabaa inay sabab u tahay dhibaatooyinka dumarka, ninka, ama labadaba.
FARMAAJO DUMAR
Madhalaysnimada haweenku waxay dhici kartaa marka:
- Ukunta ama uurjiifku ma noolaanayo mar haddii ay ku dhegaan dahaarka ilmo galeenka (ilmo galeenka).
- Ukunta la bacrimiyey kuma xirna dahaarka ilmo-galeenka.
- Ukuntu ugama dhaqaaqi karto ugxansidaha ugana guuri karto ilmo galeenka.
- Ugxan sideyaashu waxay leeyihiin dhibaatooyin soo saarista ukunta.
Madhalaysnimada dumarka waxaa sababi kara:
- Xanuunada 'autoimmune disorders', sida antiphospholipid syndrome (APS)
- Ciladaha dhalashada ee saameeya marinka taranka
- Kansarka ama buro
- Xanuunada dharka
- Sonkorowga
- Cabitaanka khamriga badan
- Jimicsi badan
- Cunno xumida ama nafaqada liidata
- Kobaca (sida fibroids ama polyps) ilmo galeenka iyo makaanka afkiisa
- Daawooyinka sida dawooyinka kimoterabiga
- Isku dheelitir la'aanta hormoonka
- Miisaan culus ama miisaan culus
- Da 'weyn
- Feeraha ugxan-sidaha iyo polycystic ugxansida cilladda (PCOS)
- Infekshinka miskaha oo keena nabar ama barar tuubooyinka ugxanta (hydrosalpinx) ama cudurka miskaha oo ku dhaca miskaha (PID)
- Nabar ka qaadista infekshinka galmada lagu kala qaado, qalliinka caloosha ama endometriosis
- Sigaar cabid
- Qalliin looga hortagayo uurka (xayiraadda tuubada) ama cillad soo noqoshada qalliinka tubal (reanastomosis)
- Cudurka qanjirka 'thyroid'
FARMAAJO RAG
Madhalaysnimada lab waxaa sababi kara:
- Tirada xawada oo yaraatay
- Xannibaad ka hortaga shahwada siideynta
- Ciladaha ku jira manida
Madhalaysnimada ragga waxaa sababi kara:
- Ciladaha dhalashada
- Daaweynta kansarka, oo ay ku jiraan kiimoteraabiga iyo shucaaca
- U soo-gaadhista kuleylka badan muddada dheer
- Isticmaalka culus ee khamriga, marijuana, ama kookaha
- Isku dheelitir la'aanta hormoonka
- Awood daro
- Caabuq
- Daawooyinka sida cimetidine, spironolactone, iyo nitrofurantoin
- Cayilka
- Da 'weyn
- Biyo-baxa soo noqnoqda
- Nabar ka qaadista infekshannada galmada lagu kala qaado (STIs), dhaawaca, ama qalliinka
- Sigaar cabid
- Sunta deegaanka
- Vasectomy ama shaqeyn la'aanta soo noqoshada vasectomy
- Taariikhda infekshinka xiniinyaha
Lamaanayaasha caafimaadka qaba ee da'doodu ka yar tahay 30 jir oo si joogto ah u galmooda waxay heli doonaan qiyaastii 20% bishiiba inay uur yeeshaan bil kasta.
Haweeneydu waa tan ugu bacriminta badan 20-keeda. Fursadda ay haweeneydu uur qaadi karto ayaa si aad ah hoos ugu dhacaysa da'da 35 (iyo gaar ahaan da'da 40). Da'da markay bacrimintu bilaabato inay hoos u dhacdo haweeneydu way ku kala duwan tahay dumarka.
Dhibaatooyinka dhalmo la'aanta iyo heerarka uur-qaadista ayaa si aad ah u kordha 35 sano ka dib. Hadda waxaa jira ikhtiyaarro ah in ugxanta la soo helo goor hore iyo keydinta haweenka jira 20-ka. Tani waxay gacan ka geysan doontaa hubinta uurka guuleysta haddii dhalmada ay dib u dhacdo illaa da'da 35. Tani waa ikhtiyaar qaali ah. Hase yeeshe, haweenka og inay u baahan doonaan inay dib u dhigaan dhalmada ayaa tixgelin kara.
Go aansashada goorta la daweynayo madhalaysnimo waxay kuxirantahay da'daada. Bixiyeyaasha xanaanada caafimaadka waxay soo jeedinayaan in dumarka kayar 30 sano isku dayaan inay kaligood uur qaadaan mudo 1 sano ah kahor baaritaanka.
Haweenka ka weyn 35 waa inay isku dayaan inay uur qaadaan 6 bilood. Haddii aysan ku dhicin waqtigaas, waa inay la hadlaan adeeg bixiyahooda.
Tijaabada dhalmo la'aanta waxay ku lug leedahay taariikh caafimaad iyo baaritaan jireed labada lamaane.
Baadhitaannada dhiigga iyo sawirka ayaa badanaa loo baahan yahay. Haweenka, kuwan waxaa ka mid noqon kara:
- Tijaabooyinka dhiigga si loo hubiyo heerarka hoormoonka, oo ay ku jiraan progesterone iyo follicle stimulating hormone (FSH)
- Qalabka guryaha lagu ogaanayo ugxaanta ugxanta
- Cabbiraadda heer kulka jirka subax kasta si loo ogaado haddii ugxan sideyaashu sii daayaan ukumo
- Imtixaanka FSH iyo clomid
- Tijaabada hormoonka Antimullerian (AMH)
- Xinjirowga jirka (HSG)
- Ultrasound-ka miskaha
- Laparoscopy
- Tijaabooyinka shaqada tayroodhka
Tijaabooyinka ragga waxaa ka mid noqon kara:
- Tijaabinta shahwada
- Baaritaanka xiniinyaha iyo guska
- Ultrasound ee xubinta taranka ragga (mararka qaarkood waa la sameeyaa)
- Tijaabooyinka dhiigga si loo hubiyo heerarka hoormoonka
- Cad ka-qaadista xiniinyaha (marar dhif ah ayaa la sameeyaa)
Daaweyntu waxay kuxirantahay sababta dhalmo la'aanta. Waxay ku lug yeelan kartaa:
- Waxbarasho iyo latalin ku saabsan xaalada
- Daaweynta bacriminta sida taranka dumarka (IUI) iyo bacriminta fitamiinada (IVF)
- Daawooyinka lagu daaweeyo infekshannada iyo cilladaha xinjirowga
- Daawooyinka ka caawiya koritaanka iyo sii deynta ukunta ugxan sidaha
Lammaanuhu waxay kordhin karaan fursadaha uur qaadista bil kasta iyagoo galmo sameeya ugu yaraan 2 maalmood kasta kahor iyo inta lagu jiro ugxanta.
Xinjirowgu wuxuu dhacaa qiyaastii 2 toddobaad kahor wareegga caadada ee soo socota (muddada) bilaabmin. Sidaa darteed, haddii haweeneydu caadada ka hesho 28-kii maalmoodba mar lamaanaha waa inay galmo sameeyaan ugu yaraan 2dii maalmoodba inta u dhexeysa 10-ka illaa 18-ka maalmood ee ay caadadoodu billaabato
Galmo galmo kahor ugxan siidaynta ayaa si gaar ah waxtar u leh.
- Shahwada waxay ku dhex noolaan kartaa jirka haweeneyda ugu yaraan 2 maalmood.
- Si kastaba ha noqotee, ukunta haweeneyda waxaa kaliya lagu bacrimin karaa shahwada 12 illaa 24 saacadood gudahood kadib marka la sii daayo.
Haweenka miisaankoodu hooseeyo ama miisaankoodu sarreeyo waxaa laga yaabaa inay kordhiyaan fursadaha ay uur ku qaadanayaan iyaga oo qaadanaya culeys caafimaad qaba.
Dad badan ayaa caawinaad u arka inay kaqaybqaataan kooxaha taakulaynta dadka walaacooda la mid ah. Waxaad weydiin kartaa bixiyahaaga inuu kugula taliyo kooxaha deegaanka.
Ilaa 5tii lamaane ugu yaraan 1 kamid ah oo laga helay madhalaysnimo ayaa aakhirkii uur yeeshay daaweyn la'aan.
Inta badan lamaanayaasha qaba madhalaysnimada waxay uur yeeshaan daaweyn kadib.
Wac daryeel caafimaad haddii aadan awoodin inaad uur yeelatid.
Kahortaga STIs, sida jabtada iyo kalamiidiya, waxay yareyn kartaa halista dhalmo la'aanta.
Joogtaynta cunto caafimaad leh, miisaan, iyo qaab nololeed ayaa kordhin kara fursadda aad uur yeelato iyo inaad yeelato uur caafimaad leh.
Ka fogaanshaha isticmaalka saliidaha xilliga galmada waxay gacan ka geysan kartaa hagaajinta shaqada shahwada.
Awood uureysiga; Uur yeelan kari weyday
- Laparoscopy-ga miskaha
- Jirka anatomi ee taranka dumarka
- Jirka anatomy taranka
- Madhalaysnimo aasaasi ah
- Shahwada
Barak S, Gordon Baker HW. Maareynta caafimaad ee dhalmo la'aanta ragga. Gudaha: Jameson JL, De Groot LJ, de Kretser DM, et al, eds. Endocrinology: Dadka waaweyn iyo carruurta. 7aad ed. Philadelphia, PA: Elsevier Saunders; 2016: cutubka 141.
Broekmans FJ, Fauser BCJM. Madhalaysnimada dumarka: qiimeynta iyo maaraynta. Gudaha: Jameson JL, De Groot LJ, de Kretser DM, et al, eds. Endocrinology: Dadka waaweyn iyo carruurta. 7aad ed. Philadelphia, PA: Elsevier Saunders; 2016: cutubka 132.
Catherino WH. Endocrinology taranka iyo dhalmo la'aanta. In: Goldman L, Schafer AI, eds. Daawada Goldman-Cecil. 26aad. Philadelphia, PA: Elsevier; 2020: cutubka 223.
Lobo RA. Dhalmo la'aan: etiology, qiimeynta ogaanshaha, maaraynta, saadaalinta. Gudaha: Lobo RA, Gershenson DM, Lentz GM, Valea FA, eds. Cilmiga Haweenka oo dhameystiran. 7aad ed. Philadelphia, PA: Elsevier; 2017: cutubka 42.
Guddiga Tababarka ee Bulshada Mareykanka ee Daawada Taranka. Qiimaynta ogaanshaha cudurka ee dumarka madhalays ah: ra'yi guddi. Bacriminta Bacriminta. 2015; 103 (6): e44-e50. PMID: 25936238 www.ncbi.nlm.nih.gov/pubmed/25936238.
Guddiga Tababarka ee Bulshada Mareykanka ee Daawada Taranka. Qiimaynta cudurka ee ragga madhalays ah: ra'yi guddi. Bacriminta Bacriminta. 2015; 103 (3): e18-e25. PMID: 25597249 www.ncbi.nlm.nih.gov/pubmed/25597249.